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Glis3 is a member of the Gli-similar subfamily. GLIS3mutations in humans lead to neonatal diabetes,
hypothyroidism, and cystic kidney disease. We generated Glis3-deﬁcient mice by gene-targeting. The
Glis3/ mice had signiﬁcant increases in the basal blood sugar level during the ﬁrst few days after
birth. The high levels of blood sugar are attributed to a decrease in the Insulin mRNA level in the
pancreas that is caused by impaired islet development and the subsequent impairment of Insulin-
producing cell formation. The pancreatic phenotypes indicate that the Glis3-deﬁcient mice are a
model for GLIS3 mutation and diabetes mellitus in humans.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Glis3 is a member of the Gli-similar (Glis) subfamily. It is a tran-
scription factor that contains ﬁve C2H2-type Kruppel-like zinc ﬁn-
ger motifs [1–4]. Mutations in GLIS3 are the cause of a rare
syndrome of neonatal diabetes mellitus and hypothyroidism
(NDH) in humans [5] that often accompanies other organ disorders
such as polycystic kidney disease (PKD) and hepatic ﬁbrosis.
Three distinct mutant alleles, NDH1-3, have been identiﬁed in
humans [5]. NDH2 and NDH3 are caused by a large deletion up-
stream of the GLIS3 gene, leading to the loss of GLIS3 expression
in the pancreas but not in the kidney. NDH1 contains a small inser-
tion in the exon region of GLIS3 that causes a frameshift and the
truncation of the GLIS3 C-terminal domain. Patients with NDH1,
unlike those with NDH2 or NDH3, have polycystic kidney disease,
suggesting that the GLIS3mutation is involved in renal cyst forma-
tion in mammals. Kang et al. recently reported that Glis3-deﬁcient
(Glis3zf/zf) mice exhibit polycystic kidney disease [6], which is a
common hereditary disorder characterized by the developmentchemical Societies. Published by E
iotechnology Center, Nagoya
apan. Fax: +81 52 789 5053.
ashimoto).of numerous cysts in the renal tubules and collecting ducts [7].
By positional cloning, we previously identiﬁed glis3 as the causal
gene of the medaka polycystic mutant [8], which manifests poly-
cystic kidney disease in pronephros and mesonephros (Hashimoto
et al., unpublished).
To develop clinical applications, the pathogenesis of neonatal
diabetes should also be addressed. Here, we describe the genera-
tion of a mouse model of neonatal diabetes by targeting the Glis3
gene.2. Materials and methods
2.1. Targeting vector and Glis3-deﬁcient mice
We established the Glis3-deﬁcient mice (Acc. No. CDB055K:
http://www.cdb.riken.jp/arg/mutant%20mice%20list.html) by using
the following procedures. A bacterial artiﬁcial chromosome (BAC)
clone containing Glis3 (RP24-282L12) was isolated from a C57BL/
6 genomic BAC library (BACPAC Resources, Oakland, CA, USA),
and the targeting vector was constructed as described previously
(http://www.cdb.riken.go.jp/arg/protocol.html [9]). PCR with the
BAC clone yielded the 7.9-kb 50-arm and the 2.8-kb 30-arm that
ﬂank exon 5, and these fragments were subsequently inserted intolsevier B.V. All rights reserved.
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vector (details regarding the vector are available from http://
www.cdb.riken.go.jp/arg/cassette.html). Primers used to isolate
the 50- and 30-arms were: 50-CTTACTGTCGACAGCTGAGATGCTCTG-
CGCTCG-30, 50-AAGGCTGATTGCGGCCGCGTCAGACTCAAAGTCGTG-
GACACC-30, 50-TCTGATTTAAATGGATGTGTGATGGTCAAGGTACC-30
and 50-TCTGCTCGAGCGTGGTCATTTTACCTGGCACAG-30. TT2
embryonic stem cells were used [10], and two independent homol-
ogous recombinant clones were subjected to chimera production.
The homozygous phenotypes of the two mouse lines generated
from the two embryonic stem cell clones were identical.
2.2. Genotyping
For PCR genotyping, the primer set (sense: 50-GGCTGCCCTA-
GAAGATACAAGCCT-30 for the wild-type allele and 50-GTACTCG-
GATGGAAGCCGGTCTTGTC-30 for the targeted allele, and antisense:
50-GAATCCTTCCCCTTGCACCAGTTA-30 for both alleles) was used to
amplify the 30 region of the targeting site. For Southern blotting,
the genomic DNA was digested with ApaI, and the 30 region ﬂank-
ing to the short arm was used as a probe. A 13.3-kb fragment and a
28.1-kb fragment were detected for the wild-type and the targeted
alleles, respectively (Fig. 1).
2.3. Histology, lectin staining, and immunohistochemistry
Organs were ﬁxed in 10% Masked Formalin (Japan Tanner Co.,
Osaka, Japan) overnight, dehydrated in an alcohol series, embed-
ded in parafﬁn, and cut into 5-lm-thick sections. For histology,
the sections were stained with hematoxylin and eosin. FITC-conju-
gated Lotus tetragonolobus agglutinin (LTA) and Rhodamine-conju-
gated Dolichos biﬂorus agglutinin (DBA) were used for lectin
staining (Vector Laboratories, Burlingame, CA, USA). For immuno-Fig. 1. Targeting of the Glis3 locus. (A) Glis3-targeting strategy. Exon 5, which is the la
neomycin cassette. (B) Southern blot analysis of F2 generations. Examples of the wild-typ
Glis3/ mice at P6. Glis3/ mice often showed ateliosis. Scale bar indicates 1 cm. (D) S
mother increased the survival rate of the homozygotes (Glis3/).histochemistry, the antibodies against Tamm–Horsfall protein
(THP), Insulin (Santa Cruz Biotechnology, CA, USA), Glucagon,
Somatostatin (Nichirei, Tokyo, Japan) and Carboxypeptidase A
(Rockland Immunochemicals, PA, USA) were used. The sections
were studied by light microscopy (Olympus BX50, Olympus, Tokyo,
Japan) or ﬂuorescent microscopy (Axio Imager D1, Carl Zeiss,
Thornwood, Germany).
2.4. Measuring basal blood sugar level
Before measuring the blood sugar level, pups were separated
from wet nurses for 2 h and subjected to PCR genotyping. Tails
were cut at approximately 1 cm from the end, and blood samples
were collected. Blood sugar levels were measured by using Anto-
sense II (Sankyo-Bayer, Tokyo, Japan).
2.5. Glucose tolerance test
Glucose solution (50 mg/ml, 3 ll) was hypodermically injected
into four Glis3+/+ pups and four Glis3/ pups.2.6. Insulin analog injection
A total of 3 ll of an Insulin analog (Novolin N100, Novo Nordisk,
Denmark) was hypodermically injected into P5 mice.2.7. RT-PCR
Using the pancreatic cDNA as a template, RT-PCR was per-
formed as follows: 30–35 cycles of 94 C for 30 s, 60 C for 30 s,
and 72 C for 1 min. Primer sequences and product sizes are shown
in Supplementary Table S1.rgest exon in Glis3 and contains most of the zinc ﬁnger motifs, was replaced by a
e (+/+), the homozygote (/) and the heterozygote (+/) are shown. (C) Glis3+/+ and
urvival rate. Separation of the wild-type (Glis3+/+ and Glis3+/) littermates from the
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3.1. Generation of Glis3-deﬁcient (Glis3/) mice
To disrupt Glis3 gene function, we replaced exon 5 with a neo
cassette (Fig. 1A and B). The resultant Glis3 allele produced aber-
rant Glis3 protein lacking all of the ﬁve zinc-ﬁngers and their C-ter-
minus. Homozygous (Glis3/) mice were born in Mendelian ratios.
Although the homozygous mice were apparently indistinguishable
from their littermates, they died within 5 days. When the wild-
type and heterozygous littermates were separated from the
mother soon after birth, the homozygotes survived for the ﬁrst
5–9 days. The homozygotes often showed severe ateliosis
(Fig. 1C), although their stomach contained milk and their urinary
bladder contained urine.
Renal lesions were evident in the Glis3/ mice at P0 (Fig. S1).
Large cysts were found in the intermediate area between the cor-
tex and the pelvis. Some of the cysts obviously originated from
Bowman’s capsules since they contained the glomerular structure
inside (Fig. S1). At P7, cysts in the intermediate area of the homo-
zygous kidney became more expanded, and tiny cysts could be rec-
ognized in the outer area (the nephrogenic zone of the cortex),
where newly formed immature nephrons are produced [11]. There
found the tubular segments dilated were positive for segment-spe-
ciﬁc lectin markers, LTA (proximal) and DBA (collecting duct), and
also positive for an antibody against THP (distal). These results
suggest that the cysts in the homozygous kidney were distributedFig. 2. Pancreatic lesions in Glis3-deﬁcient mice. (A) Blood sugar levels at P0, P1, and
homozygotes were signiﬁcantly higher than the values in the wild-type mice at all stag
solution, the blood sugar level was measured at the time points indicated. In Glis3+/+ mi
decreased to 174.75 ± 29.58 at 160 min. In Glis3/ mice, the blood glucose level was extr
160 min (426.75 ± 145.12). Four pups in each group were tested. (C) RT-PCR of pancreati
gcg, Glucagons; sst, Somatostatin; ppy, Pancreatic polypeptide; ghr1, Ghrelin. Beta-Actin (act)
Glis3/ mice at P5 (n = 3) were measured 3 h after receiving an Insulin analog. The
597.75 ± 97.75 mg/dL to 52.0 ± 17.03 mg/dl (P < 0.01).along all of the renal tubular segments in addition to the Bowman’s
space. Since this polycystic kidney disease phenotype in Glis3-deﬁ-
cient mice was already reported by Kang et al. [6], our results are
presented in the Supplementary data (Fig. S1). Histology of the thy-
roid also suggested hypothyroidism in Glis3/ mice (Fig. S2).
3.2. Pancreatic lesions of Glis3/ mice
Pancreatic defects were expected in the Glis3/ mice because
Glis3 mRNA is highly expressed in the pancreas and human pa-
tients with GLIS3 mutations have diabetes [12]. We examined the
basal blood sugar level of Glis3/ mice at P0, P1, and P7
(Fig. 2A). At all time points, the blood sugar level was signiﬁcantly
higher in the homozygotes than in the wild-type mice, indicating
that the Glis3/ mice had neonatal diabetes that mimics the lesion
in human patients with GLIS3 mutations.
To determine if the high blood sugar level is caused by impaired
glucose metabolism in Glis3/ mice, we performed glucose toler-
ance tests. The blood sugar level of the homozygous littermates re-
mained high at 160 min after glucose administration, whereas in
the wild-type littermates the glucose was cleared from the blood
after 80 min (Fig. 2B). These results indicated that Glis3/ mice
were glucose intolerant.
We performed RT-PCR to examine the mRNA expression of pan-
creatic hormones. The levels of both Insulin1 and Insulin2 mRNA
were severely reduced in Glis3/ mice as compared with Glis3+/+
mice (Fig. 2C). Glucagon and Somatostatin mRNAs were also de-P7. Checked box (left), Glis3+/+; shadowed box (right), Glis3/. The values in the
es (P < 0.01). (B) Glucose tolerance test in P6 mice. After administration of glucose
ce, the value transiently increased to 264.25 ± 113.77 at 40 min and then gradually
emely high at 475.75 ± 134.81 at 40 min, and no marked decrease was observed for
c hormones. Three Glis3+/+ mice and three Glis3/ mice were examined. ins, Insulin;
was used as an internal control. (D) Insulin administration. The blood sugar levels in
Insulin analog injection caused a signiﬁcant reduction in blood sugar level from
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lin were slightly affected (Fig. 2C).
We also examined the Insulin sensitivity of Glis3/ mice. Hypo-
dermic injection of an Insulin analog reduced the blood sugar level
in the homozygotes to a low level (Fig. 2D), indicating that Glis3/
mice are Insulin-sensitive.
3.3. Development of pancreatic islets
To determine the mechanism responsible for the elevated
blood sugar level and the reduced pancreatic hormonal expres-
sion in Glis3/ mice, we performed histological and immunohis-
tochemical analyses of the pancreas. Hematoxylin/eosin-stained
pancreatic sections revealed that the typical architecture of the is-
lets (as seen in Glis3+/+ mice) was much smaller in Glis3/ mice
(Fig. 3A–D). The sectional-area of the islets was signiﬁcantly re-
duced in the homozygous pancreas (Fig. 3E). The pancreatic exo-Fig. 3. Langerhans islands in Glis3-deﬁcient mice. (A, B) Glis3+/+ P0 mice. (C, D) Glis3/ P0
mice than in Glis3+/+mice (P < 0.01). Scale bars represent 50 lm. Arrows point to the typic
measured in wild-type mice (n = 3) and homozygous mice (n = 3). Each dot represents th
the individual. The results from the Glis3+/+ mice are colored in black and those from thcrine cells did not seem to be altered in number or sectional area
in Glis3/ mice. Immunohistochemistry revealed that Insulin-po-
sitive cells were remarkably decreased in the Glis3/ pancreas
(Fig. 4A and B). The numbers of Glucagon-positive cells and
Somatostatin-positive cells were also decreased in the homozy-
gotes (Fig. 4C–F).
3.4. Unaltered formation of Carboxypeptidase A-positive cells in
Glis3/ pancreas
To determine the involvement of Glis3 in the development of
pancreatic islets, we used RT-PCR to examine the expression of
the genes that are important for pancreas development. Expression
of NeuroD1, Neurogenin3, and Pax6 mRNAs, which is required for
normal development of pancreatic endocrine cells [13–19], was
markedly reduced in P0 Glis3/ mice (Fig. 4I). However, the pan-
creatic mRNA expression of Hnf6, which is required for early induc-mice. Typical histological structures of the islet were signiﬁcantly smaller in Glis3/
al tissues found in the pancreas. (E) The sectional-area of the Langerhans islands was
e area of each islet from the same individual. Horizontal bars indicate the average of
e Glis3/ mice in gray. is, islet; exo, exocrine cell; du, ductal cell.
Fig. 4. Development of pancreatic endocrine cells. (A–H) Immunohistochemistry.
(A, B) Insulin. (C, D) Glucagon. (E, F) Somatostatin. (G, H) Carboxypeptidase A. (A–H)
3,30-Diaminobenzidine, tetrahydrochloride-staining. (G, H) Counter-stained with
hematoxylin. (A, C, E, G) Glis3+/+ P0 mice. (B, D, F, H) Glis3/ P0 mice. Scale bars
represent 100 lm. (I) RT-PCR for NeuroD1, Pax6, Neurogenin3 (Ngn3), and Hnf6. b-
Actin (Act) was used as an internal control. Insulin, Glucagon, and Somatostatin are
positive in Langerhans islands. The CPA signal is strong in the exocrine cells but
weak in the islets (is) and the ductal cells (du).
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markedly altered in the homozygotes.
To further examine if the differentiation of pancreatic exocrine
cells was affected by the loss of Glis3, we examined the expression
of Carboxypeptidase A (CPA), which is speciﬁc to the distal tips of
the branching epitheliumwhen tip cells commit to an exocrine fate
[21]. CPA-positive cells were normally formed in Glis3/ mice
(Fig. 4G and H).4. Discussion
We successfully generated Glis3-deﬁcient mice as a murine
model of human neonatal diabetes caused by the GLIS3 mutation.
The Glis3/ mice appeared normal at birth. However, they died in
early infancy, as do some of human neonates with this mutation
[5,12]. Glis3+/ mice showed no apparent phenotypes, which is con-
sistent with the rarity of this genetic disease in humans. Glis3/
mice exhibited two remarkable lesions, diabetes and polycystic kid-
ney disease. Hypothyroidism, which occurs in human patients with
GLIS3mutations, was evident at P7 in Glis3-deﬁcient mice (Fig. S2).
We previously found that the polycystic kidney disease patho-
genesis in the medaka polycystic mutant is caused by the glis3
mutation (Hashimoto et al., unpublished). Like the medaka poly-
cystic mutant and the human NDH1 patients [5,8], loss of Glis3
led to severe polycystic kidney disease in mice (Fig. S1). While
the loss of Glis2, a molecule homologous to Glis3, has been re-
ported to result in nephronophthisis with renal atrophy [22],
Glis3-deﬁcient mice exhibit polycystic kidney disease accompanied
by renomegaly. These results suggest that the members of the GLIS
family have differential functions in the mammalian kidney.
Glis3 is expressed in the pancreas of mice [4], and GLIS3 muta-
tions lead to neonatal diabetes in humans [5]. Although glis3 is ex-
pressed in the pancreas of medaka, its mutation in the medaka
polycystic mutant causes no apparent pancreatic phenotype
(Hashimoto et al., unpublished). In the present study, the Glis3-
deﬁcient mice clearly exhibit severe neonatal diabetes, which pre-
sumably reﬂects impairment of the pancreatic Insulin-positive
endocrine cells. The sectional-area occupied by the Langerhans is-
lands was signiﬁcantly decreased in the homozygotes. However,
Glis3 mutation did not disturb the formation of the CPA-positive
pancreatic exocrine cells. These results imply that Glis3 is neces-
sary for proper differentiation of pancreatic endocrine cells but
not for the normal formation of the pancreatic exocrine cells or
progenitor cells. Reduction of NeuroD1, Neurogenin3, and Pax6
expression levels in the pancreas of Glis3/ mice also supports
the speculation that Glis3 is required for proper differentiation of
pancreatic endocrine cells. Our results are consistent with a previ-
ous report that describes in vitro knockdown of Glis3 in cultured
pancreatic cells [23]. Although further studies are necessary, our
results together with the development of Glis3-deﬁcient mice pro-
vide an opportunity and an experimental model for understanding
the human syndrome of neonatal diabetes with GLIS3 mutations.
GLIS3 might become a critical factor in the development of tech-
nology for pancreatic genetic programming in the ﬁeld of regener-
ative medicine [18,24,25].Acknowledgments
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